Parexel's Owner Said to Weigh Sale of Drug-Testing Company, Said to Seek Value of About $9 Billion - Bloomberg
Parexel's Owner Said to Weigh Sale of Drug-Testing Company, Said to Seek Value of About $9 Billion - Bloomberg
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- WeWork to sell 27% stake held in India unit via Rs 1,200 crore secondary deal - Bloomberg
- Wells Fargo (WFC) Weighs Debut Risk Transfer as Banks Shore Up Capital - Bloomberg
- Wolfspeed pops as activist investor urges firm to consider options, including sale
Create E-mail Alert Related Categories
Private Company News, RumorsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!